Ashish M. Kamat
After graduating from the University of Bombay, Dr. Kamat completed a residency in urology at West Virginia University under the guidance of Dr Donald L. Lamm. He subsequently completed a fellowship in Urologic Oncology at University of Texas M.D. Anderson Cancer Center and joined the faculty at M.D. Anderson Cancer Center in July, 2003 with a dual appointment in the Departments of Urology and Cancer Biology.His area of clinical and research expertise is in the arena of bladder cancer. He has given numerous presentation and invited lectures, conducted symposiums, and has authored editorials and publications in several journals. He serves on the editorial board of Expert Reviews in Anticancer Therapy and as a reviewer for journals as Journal of Urology, Urology, Cancer, British Journal of Urology, Journal of the National Medical Association, and BMC Cancer and is listed in 'Who's Who in Medicine'.
He currently is actively involved in basic, translational and clinical research focusing on issues related to chemoprevention, carcinogenesis and novel therapies in bladder cancer, and is the recipient of peer-reviewed research funding including awards from the National Cancer Institute. He serves as co-project PI on the MD Anderson Cancer Center GU (Bladder) SPORE, which is the only one of its kinds in the country. He is an active member of the American Urological Association and a member of the Society of Urologic Oncology and is active in many organizations including Cancer Support Groups for patients such as the Bladder WebCafe and Bladder Cancer Advocay Network (BCAN).
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2008 UroToday ® All Rights Reserved |
